Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
18 Years
N/A
Female
Gynecologic Cancer, Breast Cancer, Thoracic Cancer, Gastrointestinal Cancer
Trial Information
Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
Inclusion Criteria:
1. Women who have a diagnosis of metastatic breast, gynecologic, thoracic, or
gastrointestinal malignancy. Women diagnosed with non-solid organ tumors (i.e.,
lymphoma, leukemia) will be excluded as their symptom profile in advanced/metastatic
disease is dissimilar.
2. Reason for admission must be for symptom management from cancer or cancer therapy.
3. Patients must be age 18 or older.
4. Only patients cared for at the Robert H. Lurie Comprehensive Cancer Center (RHLCCC)
will be eligible for this small pilot study.
5. Patients must not be enrolled in hospice care.
6. Patients must have a performance status 0-3 (ECOG scale).
7. Patients must be alert and oriented to time, place, and person. Must be able to
answer questions.
8. Patients must be able to speak, read, and communicate in English.
9. Patients must have a signed consent and authorization for research and be amenable to
be followed for outcomes/response throughout and after hospitalization.
Exclusion Criteria:
-
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Identify perceived symptom burden and quality of life in our female patients with advanced gynecologic, breast, thoracic, or gastrointestinal malignancies.
Outcome Description:
We will compare the symptom scores of the control and the intervention groups to determine if the overall symptom burden scores are lower and patient satisfaction scores are higher in the group who receive targeted intervention combined with education.
Outcome Time Frame:
3 years
Safety Issue:
No
Principal Investigator
Emily Berry, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Northwestern University
Authority:
United States: Institutional Review Board
Study ID:
STU00064629
NCT ID:
NCT01833637
Start Date:
October 2012
Completion Date:
October 2015
Related Keywords:
- Gynecologic Cancer
- Breast Cancer
- Thoracic Cancer
- Gastrointestinal Cancer
- Advanced Care Planning
- Palliative Care
- Women
- Breast Neoplasms
- Thoracic Neoplasms
- Gastrointestinal Neoplasms
Name | Location |
|---|---|
| Northwestern Memorial Hospital | Chicago, Illinois 60611 |
